8-KMaterial AgreementsExhibits & Filings

HCA Healthcare, Inc. 8-K Report, Material Agreement (Feb 2, 2005)

Filed February 2, 2005For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on February 2, 2005, to report on material definitive agreements related to executive compensation. Specifically, the Compensation Committee of the Board of Directors approved the issuance of restricted shares and non-qualified stock options to executive officers under the HCA 2000 Equity Incentive Plan. This action is a routine part of executive compensation packages and signals the company's commitment to retaining and incentivizing its key leadership. These awards are designed to align executive interests with shareholder value through equity ownership and the potential appreciation of stock value. The vesting schedules and acceleration clauses in the event of a change in control, retirement, death, or disability are standard provisions aimed at both retention and providing security to executives under certain circumstances. Investors should note that this filing primarily concerns executive compensation practices rather than significant operational or financial changes.

Key Highlights

  • 1HCA's Compensation Committee awarded restricted shares and non-qualified stock options to its executive officers on January 27, 2005.
  • 2These awards were made under the HCA 2000 Equity Incentive Plan.
  • 3Restricted shares vest ratably over three years (33.3% increments) with full vesting upon change in control, retirement, death, or disability.
  • 4Stock options are granted in four equal installments throughout 2005, with exercise prices at fair market value on the grant date.
  • 5Stock options vest ratably over four years, with acceleration upon change in control, retirement, death, or disability.
  • 6The filing includes the forms of the Restricted Share Award Agreement and Non-Qualified Stock Option Agreement as exhibits.
  • 7This report focuses on executive compensation and does not disclose changes in financial performance or material business operations.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report that HCA's Compensation Committee has approved and granted restricted stock and non-qualified stock options to the company's executive officers. This action is considered a material definitive agreement related to executive compensation.

The restricted shares vest over three years in 33.3% increments, with earlier vesting possible under specific conditions like a change in control, retirement, death, or disability. The stock options are granted in four installments throughout 2005, vest over four years, and have an exercise price equal to the fair market value on the grant date. Vesting can also be accelerated under similar conditions as the restricted shares.

These awards are a form of executive compensation designed to incentivize performance and align executive interests with those of shareholders. While they represent potential future dilution as options are exercised and restricted shares vest, they are standard practice for companies seeking to attract and retain top talent. The filing itself does not indicate any immediate impact on the company's financial performance or stock price, as it pertains to compensation arrangements.

No, this 8-K filing does not provide any financial results or operational updates for HCA. It is solely focused on disclosing the details of material definitive agreements related to executive compensation, specifically the award of restricted stock and stock options to executive officers.